Top

Published in:

01-06-2009

Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis

Authors: Jennifer Permuth-Wey, Kathleen M. Egan

Published in: Familial Cancer | Issue 2/2009

Abstract

Epidemiologic evidence suggests a family history of pancreatic cancer (PC) is a risk factor for the disease, yet the magnitude of risk varies between studies. We performed a systematic review of studies that quantified familial risks of PC, and through a meta-analysis, obtained more precise estimates of familial risk. A MEDLINE search identified published studies that reported relative risks (RR) of PC associated with a family history of the disease. A random effects model was used to summarize study-specific RRs and 95% confidence intervals (CI). Sensitivity and sub-group analyzes were performed. Seven case–control and two cohort studies involving 6,568 PC cases were identified. There was no evidence of statistical heterogeneity between studies (I² = 0%; P = 0.483). Results from case–control (RR = 2.82; 95% CI: 1.99–3.66) and cohort (RR = 1.62; 95% CI: 1.28–1.97) studies showed a significant increase in PC risk associated with having an affected relative, with an overall summary RR = 1.80 (95% CI: 1.48–2.12). Similar RR were observed for early (RR = 2.69; 95% CI: 0.56–4.82) and later (RR = 3.41; 95% CI: 0.79–6.03) onset disease in the index case. Data was too sparse to generate an overall summary RR based on the number or type of affected relatives. Individuals with a family history of PC have nearly a two-fold increased risk for developing PC compared to those without such a history. Families with two or more PC cases may benefit from comprehensive risk assessment that involves collection of detailed family history information and data regarding various risk factors for PC, especially smoking history. Those at highest risk may be referred to screening programs and studies; these are important steps toward early detection and greater odds of surviving this disease.

American Cancer Society Cancer Facts and Figures (2008). Atlanta: American Cancer Society 2008

Ahlgren JD (1996) Epidemiology and risk factors in pancreatic cancer. Semin Oncol 23(2):241–250PubMed

Boyle P, Maisonneuve P, Bueno de Mesquita B et al (1996) Cigarette smoking and pancreas cancer: a case–control study of the search programme of the IARC. Int J Cancer 67(1):63–71. doi:10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO;2-DPubMedCrossRef

Gold EB, Goldin SB (1998) Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 7(1):67–91PubMed

Lowenfels AB, Maisonneuve P (2006) Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2):197–209. doi:10.1016/j.bpg.2005.10.001 PubMedCrossRef

Schottenfeld DFJF (2006) Cancer epidemiology and prevention. [Book; Internet resource date of entry: 20050714] [Cited; 3rd: [xviii, 1392 p.: ill., maps; 29 cm.]. Available from: http://www.loc.gov/catdir/enhancements/fy0637/2005051838-d.html Materials specified: Publisher description http://www.loc.gov/catdir/enhancements/fy0637/2005051838-d.htmlMaterials specified: Table of contents only http://www.loc.gov/catdir/enhancements/fy0637/2005051838-t.html

MacDermott RP, Kramer P (1973) Adenocarcinoma of the pancreas in four siblings. Gastroenterology 65(1):137–139PubMed

Evans JP, Burke W, Chen R et al (1995) Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis. J Med Genet 32(5):330–335PubMedCrossRef

Klein AP, Brune KA, Petersen GM et al (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64(7):2634–2638. doi:10.1158/0008-5472.CAN-03-3823 PubMedCrossRef

10.

Brand RE, Lynch HT (2000) Hereditary pancreatic adenocarcinoma: a clinical perspective. Med Clin North Am 84(3):665–675. doi:10.1016/S0025-7125(05)70249-2 PubMedCrossRef

11.

Hruban RH, Petersen GM, Ha PK, Kern SE (1998) Genetics of pancreatic cancer: from genes to families. Surg Oncol Clin N Am 7(1):1–23PubMed

12.

Bartsch DK, Sina-Frey M, Lang S et al (2002) CDKN2A germline mutations in familial pancreatic cancer. Ann Surg 236(6):730–737. doi:10.1097/00000658-200212000-00005 PubMedCrossRef

13.

Giardiello FM, Brensinger JD, Tersmette AC et al (2000) Very high risk of cancer in familial Peutz–Jeghers syndrome. Gastroenterology 119(6):1447–1453. doi:10.1053/gast.2000.20228 PubMedCrossRef

14.

Goggins M, Schutte M, Lu J et al (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56(23):5360–5364PubMed

15.

Gruber SB, Entius MM, Petersen GM et al (1998) Pathogenesis of adenocarcinoma in Peutz–Jeghers syndrome. Cancer Res 58(23):5267–5270PubMed

16.

Hahn SA, Greenhalf B, Ellis I et al (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95(3):214–221PubMedCrossRef

17.

Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W (2000) Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 87(6):809–811. doi:10.1002/1097-0215(20000915)87:6<809::AID-IJC8>3.0.CO;2-UPubMedCrossRef

18.

Watson P, Lynch HT (1993) Extracolonic cancer in hereditary non-polyposis colorectal cancer. Cancer 71(3):677–685. doi:10.1002/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#PubMedCrossRef

19.

Whitcomb DC, Applebaum S, Martin SP (1999) Hereditary pancreatitis and pancreatic carcinoma. Ann NY Acad Sci 880:201–209. doi:10.1111/j.1749-6632.1999.tb09524.x PubMedCrossRef

20.

Oberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19(5):753–781. doi:10.1016/j.bpg.2005.06.002 PubMedCrossRef

21.

Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M (2001) Familial pancreatic cancer. Cancer J 7(4):266–273PubMed

22.

Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131(4):247–255PubMed

23.

Canto MI (2007) Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol 34(4):295–302. doi:10.1053/j.seminoncol.2007.05.008 PubMedCrossRef

24.

Canto MI, Goggins M, Hruban RH et al (2006) Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4(6):766–781. doi:10.1016/j.cgh.2006.02.005 (Quiz 665)PubMedCrossRef

25.

Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012. doi:10.1001/jama.283.15.2008 PubMedCrossRef

26.

Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 18(6):805–835PubMedCrossRef

27.

Breslow NE, Day NE (1980) Statistical methods in cancer research Volume I: the analysis of case–control studies. IARC Sci Publ 32:5–338PubMed

28.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188. doi:10.1016/0197-2456(86)90046-2 PubMedCrossRef

29.

Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186 PubMedCrossRef

30.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMed

31.

Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101. doi:10.2307/2533446 PubMedCrossRef

32.

Coughlin SS, Calle EE, Patel AV, Thun MJ (2000) Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11(10):915–923. doi:10.1023/A:1026580131793 PubMedCrossRef

33.

Falk RT, Pickle LW, Fontham ET, Correa P, Fraumeni JF Jr (1988) Life-style risk factors for pancreatic cancer in Louisiana: a case–control study. Am J Epidemiol 128(2):324–336PubMed

34.

Fernandez E, La Vecchia C, D’Avanzo B, Negri E, Franceschi S (1994) Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 3(3):209–212PubMed

35.

Ghadirian P, Liu G, Gallinger S et al (2002) Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas. Int J Cancer 97(6):807–810. doi:10.1002/ijc.10123 PubMedCrossRef

36.

Hassan MM, Bondy ML, Wolff RA et al (2007) Risk factors for pancreatic cancer: case–control study. Am J Gastroenterol 102(12):2696–2707. doi:10.1111/j.1572-0241.2007.01510.x PubMedCrossRef

37.

Inoue M, Tajima K, Takezaki T et al (2003) Epidemiology of pancreatic cancer in Japan: a nested case–control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol 32(2):257–262. doi:10.1093/ije/dyg062 PubMedCrossRef

38.

Schenk M, Schwartz AG, O’Neal E et al (2001) Familial risk of pancreatic cancer. J Natl Cancer Inst 93(8):640–644. doi:10.1093/jnci/93.8.640 PubMedCrossRef

39.

Silverman DT, Schiffman M, Everhart J et al (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80(11):1830–1837. doi:10.1038/sj.bjc.6690607 PubMedCrossRef

40.

Ghadirian P, Boyle P, Simard A, Baillargeon J, Maisonneuve P, Perret C (1991) Reported family aggregation of pancreatic cancer within a population-based case–control study in the Francophone community in Montreal, Canada. Int J Pancreatol 10(3–4):183–196PubMed

41.

Bartsch DK, Kress R, Sina-Frey M et al (2004) Prevalence of familial pancreatic cancer in Germany. Int J Cancer 110(6):902–906. doi:10.1002/ijc.20210 PubMedCrossRef

42.

McWilliams RR, Bamlet WR, Rabe KG, Olson JE, De Andrade M, Petersen GM (2006) Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma. Clin Gastroenterol Hepatol 4(9):1143–1147. doi:10.1016/j.cgh.2006.05.029 PubMedCrossRef

43.

McWilliams RR, Rabe KG, Olswold C, De Andrade M, Petersen GM (2005) Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma. Cancer 104(2):388–394. doi:10.1002/cncr.21166 PubMedCrossRef

44.

Price TF, Payne RL, Oberleitner MG (1996) Familial pancreatic cancer in south Louisiana. Cancer Nurs 19(4):275–282. doi:10.1097/00002820-199608000-00003 PubMedCrossRef

45.

Del Chiaro M, Zerbi A, Falconi M et al (2007) Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology 7(5–6):459–469. doi:10.1159/000108963 PubMedCrossRef

46.

James TA, Sheldon DG, Rajput A et al (2004) Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer 101(12):2722–2726. doi:10.1002/cncr.20700 PubMedCrossRef

47.

Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600–1608. doi:10.1093/jnci/86.21.1600 PubMedCrossRef

48.

Hemminki K, Li X (2003) Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 103(4):525–530. doi:10.1002/ijc.10863 PubMedCrossRef

49.

Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA (2003) Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 124(5):1292–1299. doi:10.1016/S0016-5085(03)00272-5 PubMedCrossRef

50.

Silverman DT (2001) Risk factors for pancreatic cancer: a case–control study based on direct interviews. Teratog Carcinog Mutagen 21(1):7–25. doi:10.1002/1520-6866(2001)21:1<7::AID-TCM3>3.0.CO;2-APubMedCrossRef

51.

Tersmette AC, Petersen GM, Offerhaus GJ et al (2001) Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 7(3):738–744PubMed

52.

Salber EJ, Macmahon B (1961) Cigarette smoking among high school students related to social class and parental smoking habits. Am J Public Health Nations Health 51:1780–1789PubMed

53.

Mitchell RJ, Brewster D, Campbell H et al (2004) Accuracy of reporting of family history of colorectal cancer. Gut 53(2):291–295. doi:10.1136/gut.2003.027896 PubMedCrossRef

54.

Percy C, Stanek EIII, Gloeckler L (1981) Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71(3):242–250PubMedCrossRef

55.

Brand RE, Lerch MM, Rubinstein WS et al (2007) Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56(10):1460–1469. doi:10.1136/gut.2006.108456 PubMedCrossRef

Title: Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis
Authors: Jennifer Permuth-Wey
Kathleen M. Egan
Publication date: 01-06-2009
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 2/2009
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-008-9214-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Analysis of BRCA1/BRCA2 genes’ contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women

High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriers

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations

Factors associated with intrusive cancer-related worries in women undergoing cancer genetic risk assessment

SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women

Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening

Keynote webinar | Spotlight on antibody–drug conjugates in cancer